Futuximab

From WikiMD.org
Jump to navigation Jump to search

Futuximab

Futuximab (pronunciation: foo-tux-i-mab) is a hypothetical monoclonal antibody used in the treatment of various cancer types. The name "Futuximab" follows the World Health Organization's guidelines for the nomenclature of monoclonal antibodies, with "-mab" indicating it is a monoclonal antibody, and "futuxi-" being a unique stem.

Etymology

The name "Futuximab" is derived from the International Nonproprietary Names (INN) system for pharmaceutical substances. The "-mab" suffix indicates that the drug is a monoclonal antibody. The prefix "Futuxi-" does not have a specific meaning in the INN system and is used for distinction among other monoclonal antibodies.

Usage

Futuximab, as a monoclonal antibody, is designed to target and bind to specific proteins on the surface of cancer cells. This binding can trigger the immune system to destroy the cancer cells. The specific proteins that Futuximab targets would depend on its design and the type of cancer it is used to treat.

Related Terms

  • Monoclonal Antibodies: A type of immune system protein made in the lab that can bind to substances in the body, including cancer cells. Futuximab is a type of monoclonal antibody.
  • Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells. Futuximab is used in the treatment of certain types of cancer.
  • World Health Organization: The global health body of the United Nations that directs and coordinates health within the United Nations system. The WHO provides guidelines for the nomenclature of monoclonal antibodies like Futuximab.
  • International Nonproprietary Names: The official non-proprietary or generic names given to pharmaceutical substances, as designated by the World Health Organization.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski